Compound Overview Class of Compound: Peptide Mechanism of Action: PT-141 is an agonist of the melanocortin receptors, with high affinity for MC4R, the stimulation of which increases sexual desire and causes sexual arousal in both men and women Notable Studies: Also Known As: Bremelanotide, bremelanotide acetate, Rekynda, Vyleesi, CID9941379 Research Applications: Sexual funtion Male sexual arousal Anti-inflammatory action Risks: Injection-related side effects Temporarily increases blood pressure Not FDA approved to treat men
Melanotan 1 vs 2: Key Differences (Beginner's Guide) Melanotan 1 vs 2 explained for beginners: how the two tanning peptides differ in receptor targets, potency, side effects, and legal status
Adoption of the Emergency Care Access & Timeliness eCQM Beginning With Optional Reporting for the CY 2027 Reporting Period/CY 2029 Program Determination a
Core Med Science is a pioneer in liposomal technology, which delivers vitamin C, glutathione, and other nutrients packaged inside a fatty liposome that resembles the membrane of human cells
What long-term safety data do we have
Modern triple agonist peptides, including Durham Peptides' retatrutide, are manufactured via Solid-Phase Peptide Synthesis with no animal-derived materials